SHH and neoplasm: Collectively, the transcriptomic changes following trametinib treatment demonstrate significant and sustained alterations in cell cycle, cell death and differentiation-related pathways, as well as genes associated with SHH pathway signaling in human and mouse SHH MB tumor cells.